Research helps hasten diagnosis and treatment of macrophage activation syndrome
How a Rheumatologist Thinks: Cognition and Diagnostic Errors in Rheumatology
The Institute of Medicine has reported that each year up to 98,000 deaths result from iatrogenic injury and error.1 Autopsy series have suggested a 15% error rate in the practice of medicine. These numbers are surprising and concerning and raise important questions about how we practice medicine. What kind of errors do we make as…
The Most Cost-Effective Diagnosis Is the Correct Diagnosis
Comments on the Medicare decision to eliminate consultation codes
Research Across the Spectrum
NIAMS director highlights innovative research initiatives
Ortho Angle
Where rheumatology and orthopedics meet
Within Our Reach–Funded Research Finds Highly Specific Markers of RA
A study recently published in Arthritis & Rheumatism concluded that anti–peptidyl arginine deiminase type 4 (PAD-4) antibodies are highly specific markers of RA and appear to be useful markers of disease severity. The project studied an important and previously unrecognized immune response in RA—anti–PAD-4, which is one of the major proteins that creates other common autoantigens in RA.
Immunizations in Immunocomprised Patients
Vaccines can help minimize certain diseases
Psoriatic Arthritis: From Leeds to the Limelight
Advances in understanding of the disease begin in the 1960s
Closer to a Cure
Over the last two years, the Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign has granted almost $9 million to 30 researchers in the hopes of finding a cure for rheumatoid arthritis (RA). These researchers are studying an array of issues, from innovative research into the genetics of RA to new treatments that will more effectively manage the disease. With the REF’s announcement of the third round of Within Our Reach grant recipients, patients with RA are closer to a cure.
Diagnosis: Myopathy
Presentation and evaluation of metabolic causes